Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$12.55 - $17.22 $146,132 - $200,509
11,644 Added 12.58%
104,227 $1.76 Million
Q4 2023

Feb 13, 2024

SELL
$9.64 - $14.59 $17,564 - $26,582
-1,822 Reduced 1.93%
92,583 $1.31 Million
Q3 2023

Nov 13, 2023

BUY
$10.3 - $15.99 $144,230 - $223,907
14,003 Added 17.42%
94,405 $972,000
Q2 2023

Aug 11, 2023

BUY
$8.48 - $16.48 $3,383 - $6,575
399 Added 0.5%
80,402 $1.33 Million
Q1 2023

May 15, 2023

BUY
$6.41 - $9.95 $5,922 - $9,193
924 Added 1.17%
80,003 $732,000
Q4 2022

Feb 13, 2023

BUY
$5.02 - $10.0 $193,526 - $385,510
38,551 Added 95.12%
79,079 $566,000
Q2 2021

Aug 13, 2021

SELL
$6.73 - $9.05 $12,901 - $17,348
-1,917 Reduced 4.52%
40,528 $272,000
Q1 2021

May 12, 2021

BUY
$6.61 - $10.07 $52,172 - $79,482
7,893 Added 22.84%
42,445 $383,000
Q3 2020

Nov 13, 2020

BUY
$5.02 - $8.98 $35,928 - $64,269
7,157 Added 26.13%
34,552 $174,000
Q2 2020

Aug 13, 2020

BUY
$7.25 - $11.75 $9,294 - $15,063
1,282 Added 4.91%
27,395 $221,000
Q1 2020

May 14, 2020

SELL
$4.06 - $10.64 $81,634 - $213,938
-20,107 Reduced 43.5%
26,113 $207,000
Q2 2019

Aug 14, 2019

BUY
$1.09 - $3.19 $10,050 - $29,414
9,221 Added 24.92%
46,220 $133,000
Q2 2018

Aug 14, 2018

BUY
$5.89 - $7.78 $143,238 - $189,201
24,319 Added 191.79%
36,999 $226,000
Q4 2017

Feb 13, 2018

SELL
$8.03 - $11.25 $75,257 - $105,435
-9,372 Reduced 42.5%
12,680 $103,000
Q3 2017

Nov 14, 2017

SELL
$8.35 - $10.5 $94,137 - $118,377
-11,274 Reduced 33.83%
22,052 $231,000
Q2 2017

Aug 14, 2017

BUY
N/A
33,326
33,326 $367,000

Others Institutions Holding AVDL

About AVADEL PHARMACEUTICALS PLC


  • Ticker AVDL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 60,581,300
  • Market Cap $661M
  • Description
  • Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...
More about AVDL
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.